Journal of Scleroderma and Related Disorders

Aims & Scope

The Journal of Scleroderma and Related Disorders, the official independent journal of the World Scleroderma Foundation and EUSTAR, is an international, multi-disciplinary, peer-reviewed publication targeted to scientists and clinicians interested in systemic sclerosis, scleroderma, and other related autoimmune and fibrotic diseases.

The journal publishes high quality, original research articles on the epidemiology, natural history, pathophysiology, diagnosis, treatment and outcome of these diseases as well as reviews and thought-provoking editorials and commentaries, with the aim of becoming the leading worldwide reference journal in the field of scleroderma and related diseases.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.2
2024	1.40

Journal Rank

Year	Value
2024	9685

Journal Citation Indicator

Year	Value
2024	247

SJR (SCImago Journal Rank)

Year	Value
2024	0.600

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	27

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

  Citation: 412

  Authors: Dinesh, Daniel E., Philip J., Yannick, Murray, Lazlo, Oliver, Ivan, Masataka, Marco, Maureen, Thomas, Peter A., Janet E., James R., Virginia, Wendy, Christopher P.

• Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities

  Citation: 275

  Authors: John, Maria, Masataka

• Interleukin-6 as a Multifunctional Regulator: Inflammation, Immune Response, and Fibrosis

  Citation: 128

  Authors: Ernest, Stefan

• Gastrointestinal manifestations of systemic sclerosis

  Citation: 123

  Authors: Andrew B., Charles, Christopher, Dinesh

• Pathogenesis of systemic sclerosis associated interstitial lung disease

  Citation: 74

  Authors: Svetlana I, Christopher P

• Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) Definition

  Citation: 71

  Authors: Yossra Atef, Cosimo, Sindhu R., Emanuela, Mohamed, Nabeel, Laura, Bethany, Dinesh, Yannick, Murray, Thomas, Ariane, Ana, Oliver, Suzanne, Christopher P., Marco, Daniel E.

• The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib

  Citation: 70

  Authors: Wenxia, Swati, Roberta Goncalves, Mary, Kathleen, Anjana, Jun, John

• Update on morbidity and mortality in systemic sclerosis–related interstitial lung disease

  Citation: 61

  Authors: Elizabeth R, Aryeh

• Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition

  Citation: 58

  Authors: Cosimo, Maya H, Daniel E, Giacomo, Aleksandra, Raluca B, Alessandro, Marija, Alexia, Kostantinos, Yossra Atef, Ivan, Anna, Ghadeer, Anastasia, Yohei, George, Lorenzo, Sophie, Luna, Alida LP, Carsten, Arsen, Karin, Sven, Elijah R, Yannick, Masataka, Christopher P, Dinesh, Thomas, Renzo, Ilaria, Elisabetta, Francesco, Petar, Marco

• Antisynthetase syndrome: A distinct disease spectrum

  Citation: 49

  Authors: Kun, Rohit

---